rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mark Heinen

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Soar AI; Chief Financial Officer, Better Therapeutics.

In numbers

Trades disclosed
20
Buys
9
Sells
0
Bought
$142K
Sold
$0
Companies
2
Companies where not an officer
0
First trade
28 Oct 2021
Last trade
27 Mar 2026
Last filed
31 Mar 2026

Companies traded

Where they are an officer
SOAR Soar AIOfficer · Airlines & Air Freight · last 27 Mar 20261 buy · 0 sells
Better TherapeuticsOfficer · last 5 Apr 20238 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 Mar 2026filed 31 Mar 2026SOAR Soar AIAirlines & Air FreightSEC FORM 4 Code A$2,60010,000 at $0.26filing
27 Mar 2026filed 31 Mar 2026SOAR Soar AIAirlines & Air FreightSEC FORM 4 Code A$2,60010,000 at $0.26filing
7 May 2025filed 9 May 2025SOAR Soar AIAirlines & Air FreightSEC FORM 4 Code A—45,000 at $0.00filing
7 Jun 2024filed 11 Jun 2024SOAR Soar AIoption or derivative · Airlines & Air FreightSEC FORM 4 Code A—47,840 at $0.00filing
7 Jun 2024filed 11 Jun 2024SOAR Soar AIAirlines & Air FreightSEC FORM 4 Code A—139,463 at $0.00filing
6 Jun 2024filed 10 Jun 2024SOAR Soar AIAirlines & Air FreightSEC FORM 4 Bought$6,8008,500 at $0.80filing
5 Apr 2023filed 21 Apr 2023Better TherapeuticsSEC FORM 4 Code A—54,000 at $0.00filing
1 Mar 2023filed 21 Apr 2023Better Therapeuticsoption or derivativeSEC FORM 4 Code A—28,550 at $0.00filing
30 Nov 2022filed 2 Dec 2022Better TherapeuticsSEC FORM 4 Code A$19K15,723 at $1.24filing
13 Sep 2022filed 14 Sep 2022Better TherapeuticsSEC FORM 4 Bought$51K26,132 at $1.94filing
12 Sep 2022filed 14 Sep 2022Better TherapeuticsSEC FORM 4 Bought$46K23,868 at $1.94filing
24 Jun 2022filed 28 Jun 2022Better TherapeuticsSEC FORM 4 Bought$3,9912,280.61 at $1.75filing
10 Jun 2022filed 10 Jun 2022Better TherapeuticsSEC FORM 4 Bought$7,8005,000 at $1.56filing
1 Apr 2022filed 4 Apr 2022Better Therapeuticsoption or derivativeSEC FORM 4 Code A—32,800 at $0.00filing
31 Mar 2022filed 4 Apr 2022Better TherapeuticsSEC FORM 4 Bought$9,9005,000 at $1.98filing
15 Dec 2021filed 15 Dec 2021Better TherapeuticsSEC FORM 4 Bought$11K2,333 at $4.70filing
14 Dec 2021filed 15 Dec 2021Better TherapeuticsSEC FORM 4 Bought$2,720500 at $5.44filing
13 Dec 2021filed 15 Dec 2021Better TherapeuticsSEC FORM 4 Bought$2,725500 at $5.45filing
28 Oct 2021filed 1 Nov 2021Better Therapeuticsoption or derivativeSEC FORM 4 Code A—51,920 at $0.00filing
28 Oct 2021filed 1 Nov 2021Better TherapeuticsSEC FORM 4 Code A—6,667filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Industrials1
Not placed8

Buys in green, sells in red, by the company’s sector.

Related people

Christopher EnseyChief Executive Officer · Chief Executive Officer at Volato Group, filing Form 4 there in the last year
Matthew LiottaChief Executive Officer · Chief Executive Officer at Volato Group, filing Form 4 there in the last year
Michael Patrick PracharChief Operating Officer · Chief Operating Officer at Volato Group, filing Form 4 there in the last year
Mike NicholsDirector · Director at Volato Group, filing Form 4 there in the last year
Christopher BurgerDirector · Director at Volato Group, filing Form 4 there in the last year